Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allopurinol and cataracts.

H Jick, D E Brandt

    American Journal of Ophthalmology
    |September 15, 1984
    PubMed
    Summary
    This summary is machine-generated.

    This study investigated the link between allopurinol use and cataracts. Findings suggest no significant association between allopurinol and cataract development in patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Epidemiology of lower limb fractures in general practice in the United Kingdom.

    Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention·2004
    Same author

    Statin use and cancer risk in the General Practice Research Database.

    British journal of cancer·2004
    Same author

    The risk of stillbirth in pregnancies before and after the onset of diabetes.

    Diabetic medicine : a journal of the British Diabetic Association·2003
    Same author

    Statin use, hyperlipidaemia, and the risk of breast cancer.

    British journal of cancer·2002
    Same author

    Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives.

    Lancet (London, England)·2001
    Same author

    Live attenuated polio vaccine and the risk of intussusception.

    British journal of clinical pharmacology·2001
    Same journal

    Reply to Comment on Visual Field Progression in Glaucoma Patients with Delayed Follow-Up.

    American journal of ophthalmology·2026
    Same journal

    Comment on: "Safety and efficiency reducing retinopathy of prematurity guideline sensitivity: an external validation using a large US-based dataset".

    American journal of ophthalmology·2026
    Same journal

    Reply to Comment on "Clinicopathological and Imaging Distinction Between Ocular Adnexal MALT Lymphoma and IgG4-Related Ophthalmic Disease".

    American journal of ophthalmology·2026
    Same journal

    Comment on: Visual Field Progression in Glaucoma Patients With Delayed Follow-Up.

    American journal of ophthalmology·2026
    Same journal

    Corneal sensitivity changes and nerve plexus abnormalities in noninfectious anterior uveitis.

    American journal of ophthalmology·2026
    Same journal

    Role of Menopausal Hormone Therapy on Strabismus, Strabismus Surgery, and Reoperation Rates.

    American journal of ophthalmology·2026
    See all related articles

    Area of Science:

    • Ophthalmology
    • Pharmacology

    Background:

    • Cataracts are a leading cause of vision impairment.
    • Allopurinol is commonly prescribed for gout and hyperuricemia.

    Purpose of the Study:

    • To investigate a potential association between allopurinol use and the incidence of cataracts.
    • To evaluate the relative risk of cataract development in allopurinol users compared to non-users.

    Main Methods:

    • Two population-based studies were conducted.
    • Study 1: Case-control study in Boston (251 cataract patients, 753 controls).
    • Study 2: Cohort study in Puget Sound (389 cataract surgery patients, 551,543 person-years).

    Main Results:

    • Study 1 showed a relative risk of 1.0 for cataract in allopurinol users versus non-users.

    Related Experiment Videos

  • Study 2 revealed no increased rate of cataract hospitalization among allopurinol users across different age groups.
  • Specifically, hospitalization rates for cataract were 0/992 person-years for users aged 30-49 and 3/2,270 person-years for users aged 50-64.

    • Conclusions:

    • The study found no evidence to support a positive association between allopurinol use and cataract development.
    • Results indicate that allopurinol is unlikely to be a risk factor for cataracts.